Safety and Tolerability of c-MET Inhibitors in Cancer

The role of aberrant hepatocyte growth factor receptor (c-MET, also known as tyrosine-protein kinase MET)/hepatocyte growth factor (HGF) signaling in cancer progression and invasion has been extensively studied. c-MET inhibitors have shown promising pre-clinical and early phase clinical trial anti-t...

Full description

Saved in:
Bibliographic Details
Published in:Drug Saf
Main Authors: Puccini, Alberto, Marín-Ramos, Nagore I., Bergamo, Francesca, Schirripa, Marta, Lonardi, Sara, Lenz, Heinz-Josef, Loupakis, Fotios, Battaglin, Francesca
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7491978/
https://ncbi.nlm.nih.gov/pubmed/30649748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-018-0780-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items